According to a market report by Lucintel, the future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
In this market, corticosteroids, vitamins, and monoclonal antibody are
the major segments of thyroid eye disease market by treatment type.
Lucintel forecasts that monoclonal antibody is expected to witness
highest growth over the forecast period.
Within this market, hospitals will remain the largest segment.
APAC is expected to witness highest growth over the forecast period due
to increasing healthcare expenditure, rising number of diseases, and rising
investments by major players in the region.
AbbVie, Novartis International, Teva Pharmaceutical Industries, Pfizer,
Sanofi S.A., Merck, Abbot Laboratories, Horizon Therapeutics, Johnson &
Johnson, and GE Healthcare are the major suppliers in the thyroid eye disease
market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D Printing Medical
Device Market
8. Medical Lifting Sling
Market
9. Liquid Biopsy Market
10. Stretcher Market
No comments:
Post a Comment